Bayer AG (BAY.F) Halts Study of Hemophilia Therapy BAY 86-6150 Due to Safety Concerns
5/7/2013
More...
|
Celltrion, Inc. Drops Late-Stage Trial of Roche (RHHBY) Rituxan Drug Copy
4/19/2013
More...
|
Clavis Pharma ASA Stops Elacytarabine Development on Negative Ph3 Trial in AML
4/3/2013
More...
|
BioLineRx Ltd. Says CLARITY Trial of BL-1020 Did Not Meet Primary Efficacy Endpoint, to Discontinue Study
3/21/2013
More...
|
Moberg Derma Discontinues Clinical Development of Limtop
3/11/2013
More...
|
Amgen (AMGN), UCB, Inc. (UCBJF.PK) Halt Testing of Fracture-Healing Drug
2/13/2013
More...
|
Ranbaxy Laboratories (RANBAXY.BO) Halts Production of Generic Lipitor
12/3/2012
More...
|
Roche (RHHBY)'s Good Cholesterol Drug Shows Negative Side Effects
11/7/2012
More...
|
Novartis AG (NVS) Stops Developing Long-Acting Version of Vanda Pharmaceuticals, Inc. (VNDA)'s Fanapt
10/12/2012
More...
|
Oxford BioMedica PLC (OXB.L) Abandons Prostate Cancer Vaccine Study
10/11/2012
More...
|
Anacor Pharmaceuticals, Inc. Says GlaxoSmithKline (GSK) Stops Development of Antibiotic
10/8/2012
More...
|
ArQule, Inc. (ARQL), Daiichi Sankyo, Inc. (4568.t) Discontinue Lung Cancer Drug Trial
10/3/2012
More...
|
Novo Nordisk A/S (NVO) Halts Development of Hemophilia Drug
10/2/2012
More...
|
Lundbeck Inc. (LUN.CO) Halts Sales of Leukemia Drug Over Supply Problems
9/17/2012
More...
|
Palatin Technologies (PTN) Says Partner AstraZeneca PLC (AZN) to Halt Further Development of Obesity Drug
9/10/2012
More...
|
Bristol-Myers Squibb Company (BMY) Ends Hepatitis C Development After Patient Death; Eats a $1.8 Billion Loss
8/27/2012
More...
|
BioInvent (BOVNF), ThromboGenics NV (TBGNF) Plunges as Development of Anticoagulent is Dropped
6/5/2012
More...
|
Q-Med AB Discontinues the Breast Indication for Macrolane
4/17/2012
More...
|
Sanofi (France) (SASY.PA) Discontinues Selling Authorized Generic Version of Lovenox
12/5/2011
More...
|
National Institutes of Health (NIH) Discontinues Tenofovir Vaginal Gel in 'Voice' HIV Prevention Study
11/29/2011
More...
|
Celgene International Sárl (CELG) Will Discontinue Phase III MAINSAIL(R) Trial in Castrate-Resistant Prostate Cancer
11/28/2011
More...
|
Moberg Derma Discontinues Preclinical Development Program for A-Fizz
10/27/2011
More...
|
Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Drops Europe Development of Insomnia Drug
10/10/2011
More...
|
Astellas Pharma Inc. (YPH.BE) Halts Development of Anti-Clotting Drug
9/29/2011
More...
|
Amylin Pharmaceuticals, Inc. (AMLN), Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Halt Obesity Drug Development Following Commercial Reassessment of the Program
8/8/2011
More...
|
BeiLu Pharma Gives Up on Melatonin-based Depression Drug
7/19/2011
More...
|
Lack of Partner Prompts Genmab A/S (GEN.CO) to Drop Zalutumumab
6/28/2011
More...
|
Diamyd Medical AB Discontinues US Phase III Trial with Type I Diabetes Product
6/24/2011
More...
|
Drugmakers Including Johnson & Johnson (JNJ) and Procter & Gamble (PG) Eliminate Infant Drops of Key Medicine
5/5/2011
More...
|
AstraZeneca PLC (AZN) Pulls Bloodthinner In France
3/24/2011
More...
|
Sanofi-Aventis (France) (SASY.PA) to Withdraw Anzemet From Five Countries
2/15/2011
More...
|
Ipsen Closes BIM 23A760 Phase II Trials For Acromegaly; Compound Does Not Meet Expectations
12/15/2010
More...
|
Roche (RHHBY) and Biogen Idec, Inc. (Massachusetts) (BIIB) Announce Decision to Discontinue Phase 3 Ocrelizumab Clinical Development Program in Patients with Rheumatoid Arthritis
5/19/2010
More...
|
Sanofi-Aventis (France) (SASY.PA) Stops 14 Candidate Drugs, Profit Up 15%
4/29/2009
More...
|
Solvay Pharmaceuticals, Inc. Ends Research on Cbesity Treatment Compound
11/17/2008
More...
|
Genmab A/S (GNMSF.PK) Announces Discontinuation of Zanolimumab Program and Job Cuts
10/8/2008
More...
|
Life Science Weekly inSite (Sep. 29 - Oct. 3)
10/6/2008
More...
|
BioAlliance Pharma Suspends Phase II/III Trial of Doxorubicin Transdrug(R) in Primary Liver Cancer
7/16/2008
More...
|